Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPS stroke prevention polypill trial
ISRCTN58452386Phase 3Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of aspirin + atorvastatin + ramipril in stroke and transient ischaemic attack (TIA) (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Systolic blood pressure. Started Sep 2015; status: terminated.
02
Drugs
aspirin + atorvastatin + ramipril
03
Conditions
stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on ISRCTN58452386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN58452386.